Fisher Wallace Laboratories nabs $2.5m

Fisher Wallace Laboratories, a provider of prescription wearable technology for the treatment of neuropsychiatric disorders, has secured $2.5 million in funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this